MedPath

Readmissions of Lung Transplant Patients in ICU.

Completed
Conditions
Lung Transplant; Complications
Interventions
Other: Colection of clinical data
Registration Number
NCT03767049
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Brief Summary

A multi-centre, prospective and observational study was carried out from August 2012 to June 2016 in five Spanish tertiary-care university hospitals with well-established lung transplant programs: Vall d'Hebron (Barcelona), Marqués de Valdecilla (Santander), 12 de Octubre (Madrid), CHUAC (A Coruña), and Reina Sofía (Córdoba).

The study population comprised all consecutive adult lung transplant recipients who required ICUr (after \>7 days post-transplant discharge from ICU) during august 2012 - June 2016 (4-yr period).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
153
Inclusion Criteria
  • All consecutive adult lung transplant recipients who required ICU readmission (after >7 days post-transplant discharge from ICU) during august 2012 - June 2016 (4-yr period).
Exclusion Criteria
  • ICU readmission < 8 days post-transplant discharge from ICU.
  • ICU readmission for early postoperative care following lung transplantation.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Lung transplant patients readmitted in ICUColection of clinical data-
Primary Outcome Measures
NameTimeMethod
Causes of ICU readmission in LT adultsAugist 1. 2012 - June 30, 2016

To assess the principal causes of ICU readmission in LT adults.

Predictors of ICU and hospital mortality.Augist 1. 2012 - June 30, 2016

To identify potential predictors of ICU and hospital mortality.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath